Granahan Investment Management - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 360 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$214,0000.0%3,536
-1.1%
0.01%
-16.7%
Q3 2019$214,000
-6.1%
3,576
+1.0%
0.01%
+9.1%
Q2 2019$228,000
-2.1%
3,541
-18.0%
0.01%
-35.3%
Q4 2018$233,000
+4.5%
4,3160.0%0.02%
+41.7%
Q3 2018$223,000
-98.3%
4,316
-98.4%
0.01%
-97.3%
Q4 2016$13,101,000
+30.5%
273,9000.0%0.45%
+36.8%
Q3 2016$10,036,000
+57.3%
273,9000.0%0.33%
+41.2%
Q2 2016$6,379,000
-33.3%
273,900
+16.1%
0.23%
-33.0%
Q1 2016$9,558,000
-27.2%
236,000
+11.3%
0.35%
-23.0%
Q4 2015$13,129,000212,0000.45%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
BB BIOTECH AG 6,913,172$330,657,00012.25%
TANAKA CAPITAL MANAGEMENT INC 84,953$4,063,0009.51%
Sicart Associates LLC 280,315$13,407,0009.26%
DOWLING & YAHNKE LLC 675,843$32,326,0003.62%
Opus Point Partners Management, LLC 77,550$3,709,0002.96%
Motley Fool Asset Management LLC 259,000$12,388,0002.75%
Motley Fool Wealth Management, LLC 333,604$15,956,0001.70%
ALTRINSIC GLOBAL ADVISORS LLC 921,174$44,060,0001.63%
PINNACLE ASSOCIATES LTD 1,572,045$75,191,0001.52%
Sonora Investment Management, LLC 121,703$5,821,054,0001.20%
View complete list of IONIS PHARMACEUTICALS INC shareholders